FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105833786> ?p ?o ?g. }

• W2105833786 endingPage "215" @default.
• W2105833786 startingPage "209" @default.
• W2105833786 abstract "Background: Anti-tumour necrosis factor (TNF)α treatments improve outcome in severe rheumatoid arthritis (RA) and are efficacious in psoriasis and psoriatic arthritis. However recent case reports describe psoriasis occurring as an adverse event in patients with RA receiving anti-TNFα therapy. Objectives: We aimed to determine whether the incidence rate of psoriasis was higher in patients with RA treated with anti-TNFα therapy compared to those treated with traditional disease-modifying antirheumatic drugs (DMARDs). We also compared the incidence rates of psoriasis between the three anti-TNFα drugs licensed for RA. Methods: We studied 9826 anti-TNF-treated and 2880 DMARD-treated patients with severe RA from The British Society for Rheumatology Biologics Register (BSRBR). All patients reported with new onset psoriasis as an adverse event were included in the analysis. Incidence rates of psoriasis were calculated as events/1000 person years and compared using incidence rate ratios (IRR). Results: In all, 25 incident cases of psoriasis in patients receiving anti-TNFα therapy and none in the comparison cohort were reported between January 2001 and July 2007. The absence of any cases in the comparison cohort precluded a direct comparison; however the crude incidence rate of psoriasis in those treated with anti-TNFα therapy was elevated at 1.04 (95% CI 0.67 to 1.54) per 1000 person years compared to the rate of 0 (upper 97.5% CI 0.71) per 1000 person years in the patients treated with DMARDs. Patients treated with adalimumab had a significantly higher rate of incident psoriasis compared to patients treated with etanercept (IRR 4.6, 95% CI 1.7 to 12.1) and infliximab (IRR 3.5, 95% CI 1.3 to 9.3). Conclusions: Results from this study suggest that the incidence of psoriasis is increased in patients treated with anti-TNFα therapy. Our findings also suggest that the incidence may be higher in patients treated with adalimumab." @default.
• W2105833786 created "2016-06-24" @default.
• W2105833786 creator A5018741279 @default.
• W2105833786 creator A5027951754 @default.
• W2105833786 creator A5036981821 @default.
• W2105833786 creator A5054757083 @default.
• W2105833786 creator A5075860605 @default.
• W2105833786 creator A5083529701 @default.
• W2105833786 creator A5085335517 @default.
• W2105833786 date "2008-04-02" @default.
• W2105833786 modified "2023-10-14" @default.
• W2105833786 title "Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register" @default.
• W2105833786 cites W1502859409 @default.
• W2105833786 cites W1543727885 @default.
• W2105833786 cites W1750902960 @default.
• W2105833786 cites W1852864784 @default.
• W2105833786 cites W1961603234 @default.
• W2105833786 cites W1969621722 @default.
• W2105833786 cites W1979364075 @default.
• W2105833786 cites W1980572660 @default.
• W2105833786 cites W1982774740 @default.
• W2105833786 cites W1983867508 @default.
• W2105833786 cites W1985763670 @default.
• W2105833786 cites W1994530220 @default.
• W2105833786 cites W1995935750 @default.
• W2105833786 cites W2005623541 @default.
• W2105833786 cites W2013361256 @default.
• W2105833786 cites W2031195706 @default.
• W2105833786 cites W2047295530 @default.
• W2105833786 cites W2048296357 @default.
• W2105833786 cites W2098767548 @default.
• W2105833786 cites W2101695974 @default.
• W2105833786 cites W2103310388 @default.
• W2105833786 cites W2106777223 @default.
• W2105833786 cites W2110177517 @default.
• W2105833786 cites W2116033495 @default.
• W2105833786 cites W2120008061 @default.
• W2105833786 cites W2121829024 @default.
• W2105833786 cites W2137833678 @default.
• W2105833786 cites W2144957867 @default.
• W2105833786 cites W2146843653 @default.
• W2105833786 cites W2149827116 @default.
• W2105833786 cites W2152507275 @default.
• W2105833786 cites W2159574407 @default.
• W2105833786 cites W2162716725 @default.
• W2105833786 cites W2163624896 @default.
• W2105833786 cites W2168089480 @default.
• W2105833786 cites W2169758620 @default.
• W2105833786 cites W2226384805 @default.
• W2105833786 cites W3024304041 @default.
• W2105833786 doi "https://doi.org/10.1136/ard.2007.087288" @default.
• W2105833786 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2605571" @default.
• W2105833786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18385277" @default.
• W2105833786 hasPublicationYear "2008" @default.
• W2105833786 type Work @default.
• W2105833786 sameAs 2105833786 @default.
• W2105833786 citedByCount "190" @default.
• W2105833786 countsByYear W21058337862012 @default.
• W2105833786 countsByYear W21058337862013 @default.
• W2105833786 countsByYear W21058337862014 @default.
• W2105833786 countsByYear W21058337862015 @default.
• W2105833786 countsByYear W21058337862016 @default.
• W2105833786 countsByYear W21058337862017 @default.
• W2105833786 countsByYear W21058337862018 @default.
• W2105833786 countsByYear W21058337862019 @default.
• W2105833786 countsByYear W21058337862020 @default.
• W2105833786 countsByYear W21058337862021 @default.
• W2105833786 countsByYear W21058337862022 @default.
• W2105833786 countsByYear W21058337862023 @default.
• W2105833786 crossrefType "journal-article" @default.
• W2105833786 hasAuthorship W2105833786A5018741279 @default.
• W2105833786 hasAuthorship W2105833786A5027951754 @default.
• W2105833786 hasAuthorship W2105833786A5036981821 @default.
• W2105833786 hasAuthorship W2105833786A5054757083 @default.
• W2105833786 hasAuthorship W2105833786A5075860605 @default.
• W2105833786 hasAuthorship W2105833786A5083529701 @default.
• W2105833786 hasAuthorship W2105833786A5085335517 @default.
• W2105833786 hasBestOaLocation W21058337861 @default.
• W2105833786 hasConcept C120665830 @default.
• W2105833786 hasConcept C121332964 @default.
• W2105833786 hasConcept C126322002 @default.
• W2105833786 hasConcept C141071460 @default.
• W2105833786 hasConcept C16005928 @default.
• W2105833786 hasConcept C167704817 @default.
• W2105833786 hasConcept C17991360 @default.
• W2105833786 hasConcept C197934379 @default.
• W2105833786 hasConcept C198451711 @default.
• W2105833786 hasConcept C2776260265 @default.
• W2105833786 hasConcept C2777077863 @default.
• W2105833786 hasConcept C2777138892 @default.
• W2105833786 hasConcept C2777226972 @default.
• W2105833786 hasConcept C2777575956 @default.
• W2105833786 hasConcept C2779722408 @default.
• W2105833786 hasConcept C2780132546 @default.
• W2105833786 hasConcept C2780564577 @default.
• W2105833786 hasConcept C44249647 @default.
• W2105833786 hasConcept C61511704 @default.
• W2105833786 hasConcept C71924100 @default.

• next